First Trimester Pregnancy Loss and the Expression of Alternatively Spliced NKp30 Isoforms in Maternal Blood and Placental Tissue by Avishai Shemesh et al.
ORIGINAL RESEARCH




University of California Los Angeles




Cruces University Hospital, Spain
Amedeo Amedei,
University of Florence, Italy
Benjamin Bonavida,




The Shraga Segal Department of
Microbiology, Immunology and
Genetics, Faculty of Health Sciences,
Ben-Gurion University of the Negev,
P.O. Box 653, Beer-Sheva 84105,
Israel
angel@bgu.ac.il
†Avishai Shemesh and Dan Tirosh
equally contributed to this work
Specialty section:
This article was submitted to Tumor
Immunity, a section of the journal
Frontiers in Immunology
Received: 25 December 2014
Accepted: 07 April 2015
Published: 01 June 2015
Citation:
Shemesh A, Tirosh D, Sheiner E,
Benshalom-Tirosh N, Brusilovsky M,
Segev R, Rosental B and Porgador A
(2015) First trimester pregnancy loss
and the expression of alternatively
spliced NKp30 isoforms in maternal
blood and placental tissue.
Front. Immunol. 6:189.
doi: 10.3389/fimmu.2015.00189
First trimester pregnancy loss and
the expression of alternatively
spliced NKp30 isoforms in maternal
blood and placental tissue
Avishai Shemesh 1,2†, Dan Tirosh 3†, Eyal Sheiner 3, Neta Benshalom-Tirosh 3,
Michael Brusilovsky 1, Rotem Segev 1, Benyamin Rosental 4 and Angel Porgador 1,3*
1 The Shraga Segal Department of Microbiology, Immunology and Genetics, Faculty of Health Sciences, Ben-Gurion
University of the Negev, Beer Sheva, Israel, 2 National Institute for Biotechnology in the Negev, Ben-Gurion University of the
Negev, Beer Sheva, Israel, 3 Department of Obstetrics and Gynecology, Faculty of Health Sciences, Soroka University
Medical Center, Ben-Gurion University of the Negev, Beer Sheva, Israel, 4 Institute for Stem Cell Biology and Regenerative
Medicine, Hopkins Marine Station, Stanford University School of Medicine, Stanford, CA, USA
Capsule: We observed that first trimester pregnancy loss is associated with an altered
expression profile of the three isoforms of the NK receptor NKp30 expressed by NKs in
PBMC and placental tissue.
In this study, we aimed to investigate whether first trimester pregnancy loss is asso-
ciated with differences in expression of NKp30 splice variants (isoforms) in mater-
nal peripheral blood or placental tissue. We conducted a prospective case–control
study; a total of 33 women undergoing dilation and curettage due to first trimester
pregnancy loss were further subdivided into groups with sporadic or recurrent preg-
nancy loss. The control group comprises women undergoing elective termination of
pregnancy. The qPCR approach was employed to assess the relative expression
of NKp30 isoforms as well as the total expression of NKp30 and NKp46 recep-
tors between the selected groups. Results show that in both PBMC and placen-
tal tissue, NKp46 and NKp30 expressions were mildly elevated in the pregnancy
loss groups compared with the elective group. In particular, NKp46 elevation was
significant. Moreover, expression analysis of NKp30 isoforms manifested a different
profile between PBMC and the placenta. NKp30-a and NKp30-b isoforms in the
placental tissue, but not in PBMC, showed a significant increase in the pregnancy
loss groups compared with the elective group. Placental expression of NKp30 acti-
vating isoforms-a and -b in the pregnancy loss groups was negatively correlated
with PLGF expression. By contrast, placental expression of these isoforms in the
elective group was positively correlated with TNFα, IL-10, and VEGF-A expression.
The altered expression of NKp30 activating isoforms in placental tissue from patients
with pregnancy loss compared to the elective group and the different correlations
with cytokine expression point to the involvement of NKp30-mediated function in
pregnancy loss.
Keywords: isoforms, natural killer, NCR, NKp30, pregnancy loss
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Introduction
Miscarriage, defined as the spontaneous loss of a fetus up to
20weeks of gestation, is the most common complication of preg-
nancy. The prevalence of miscarriage is around 15% in clinically
proven pregnancies, and up to 30% in “chemical pregnancies” (1–
4). Recurrent pregnancy loss (RPL) is a term classically used in
cases of three or more spontaneous miscarriages, with a preva-
lence of 1% of couples attempting to conceive. In recent years,
the term was redefined to include two or more miscarriages,
resulting in a prevalence of 3–5% of these couples (5–7). This
change in definition is due to evidence showing that the risk
of recurrence after two pregnancy losses is around 30%, similar
to the risk of recurrence after three or more pregnancy losses
(1, 3, 8, 9). Different etiologies have been suggested for mis-
carriages, including anatomic, genetic, endocrine, and immune
disorders, as well as various infections and environmental fac-
tors. Workup studies aimed at detecting these etiologies are
carried out after two or three pregnancy losses (especially in
older, nulliparous women). Only in about 50% of these cases is
an etiology recognized; the other cases are either of unknown
etiology or thought to result from a combination of several
etiologies (10–12).
NKp30 is a 30-kDa triggering receptor expressed on resting
and activated natural killer (NK) cells (13). This receptor belongs
to a family known as natural cytotoxicity receptors (NCRs) that
includeNKp46 andNKp44 (14). El Costa et al. showed thatNKp30
and NKp46 on decidual NK (dNK) cells have a differential role in
the early stage of pregnancy (15). Activation of NKp30 on dNK by
mAb specific engagement triggers the synthesis and secretion of
various cytokines. Moreover, it was shown that adherent decidual
cells are recognized by NKp30–hFc fusion (16, 17).
Recently, it was shown that the human NKp30-encoding gene
(NCR3) is transcribed in six different splice variants, amongwhich
the most highly expressed are NKp30-a, NKp30-b, and NKp30-c
(18). Zitvogel et al. have previously published that the status and
ratio of these isoforms predict the clinical outcomeof patientswith
gastrointestinal stromal tumor (GIST). Preferential expression of
the immunosuppressive NKp30-c isoform was associated with
poor prognosis in these patients (19). In an additional study, the
same group investigated NKp30-a and NKp30-c isoform ratios in
untreated HIV-1-infected patients (18).
The reported function of NKp30 in pregnancy and pregnancy
disorders and the differential expression of NKp30 activating and
suppressive isoforms in cancer and HIV motivated the current
study. We compared (i) patients with RPLs (>2 spontaneous
miscarriages), (ii) patientswith sporadic pregnancy loss (2 spon-
taneous miscarriages), and (iii) patients undergoing elective ter-
mination of pregnancy (TOP) in the first trimester due to medical
or social considerations or fetal malformations as a control group.
The aims of this prospective case–control study were to investi-
gate whether first trimester pregnancy losses are associated with
(A) differences in mRNA expression of the expression profile of
NKp30 isoforms, as well as the total NKp30 andNKp46 expression
in maternal blood and placental tissue; and (B) the correlation
of NKp30, NKp46, and isoform expression with early pregnancy-
related cytokines.
Materials and Methods
Study Design and Population
A single center prospective case–control study was conducted in
the Department of Obstetrics and Gynecology at the Soroka Uni-
versity Medical Center, Beer Sheva, Israel in collaboration with
the Clinical Biochemistry Laboratory at Ben-Gurion University.
The study was approved by the ethical institutional review board
(in accordance with the Helsinki declaration, Approval number:
0267-12-SOR).
The study population comprises women who presented to the
Soroka Medical Center for dilation and curettage (D&C) during
the first trimester of pregnancy (<14weeks of gestation), who
consented to participate in the study. The combined study group
comprises women undergoing D&C due to first trimester preg-
nancy loss, who were subdivided into groups with sporadic or
RPL (>2 previous spontaneous miscarriages). The control group
comprises women undergoing elective TOP. Women with known
uterine anomalies, multiple gestations, and women undergoing
elective curettage who had a history of2 spontaneous pregnancy
loss were excluded from the study. The PBMC samples were elec-
tive n= 10, sporadic n= 16, recurrent n= 7, and Sp+Re n= 23,
and the placental tissue samples were elective n= 7, sporadic
n= 16, recurrent n= 7, and Sp+Re n= 23.
Blood Samples, PBMC Isolation, and Placental
Tissue Samples
Collection of blood samples was performed using a BD Vacu-
tainer® CPT™ Cell Preparation Tube with sodium heparin (REF
362753). PBMC samples were isolated according to the man-
ufacturer’s instructions. Placental tissue samples were collected
from the retrieved specimen, just after curettage, and placed
in sterile ice-cold 1 PBS until RNA extraction was per-
formed.
RNA Extraction and Reverse Transcription PCR
Total RNA was extracted from fresh placenta tissue and isolated
PBMC using the RNeasy® Mini Kit (cat# 74104, Qiagen Ltd.)
according to the manufacturer’s instructions and was stored at
 80°C until further use. RNA concentration and purity were
assessed by NanoDrop (ND1000 v3.7.1; NanoDrop Technolo-
gies, DE, USA). Reverse transcription PCR (RT-PCR) was per-
formed using a High Capacity cDNA Reverse Transcription
Kit (cat# 4368814, Applied Biosystems). cDNA synthesis was
performed according to the manufacturer’s instructions using
1 µg of total RNA and was performed for all of the samples
at the same time. cDNA samples were stored at  20°C until
further use.
Real Time PCR and Primer Set Efficiencies
qPCR analysis was performed to determine and compare the
expression of target genes using the Power SYBR® Green PCR
Master Mix (cat# 4367659, Applied Biosystems). Twenty micro-
liters of reactions were set-up in duplicate for each sample accord-
ing to the manufacturer’s instructions. Each reaction contained
30 ng of cDNA. qPCR experiments were performed using the
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Applied Biosystems 7500 Real Time PCR system, software v2.0.5.
Reaction cycling protocol was 95°C for 10min, then 40 cycles
with a 2-step program (95°C for 15s, 60°C for 1min). Collec-
tion of data was performed during the annealing step. Expres-
sion levels of NKp46, NKp30, NKp30-a, NKp30-b, NKp30-c,
IFNγ, TNFα, IL-10, PLGF, and VEGF (target genes) were nor-
malized to β-actin (reference gene). For each gene, all sam-
ples per tissue (blood or placenta) were checked in the same
plate. Plate normalization was performed by checking the β-
actin of two fixed samples in each plate and adjusting Ct
values accordingly. Calculation of gene expression was per-
formed using the 2 ∆Ct= 2 (Target gene Ct)  (Reference gene Ct) method.
Ratio analysis of NKp30 isoforms was calculated using the
NKp30x/NKp30y= 2(∆∆Ct NKp30y ∆∆Ct NKp30x) formula, as previ-
ously described (18). Primer efficiencies were tested on cDNA
pools, obtained by taking 30 ng from each cDNA sample, orig-
inated from PBMC or placental tissue samples (cDNA pools
were serial diluted five times (1:10 dilutions) and were used as
templates).
NKp46: Fw primer: 50-GTGACCACAGCCCACCGAG-03,
Rev-primer: 50-CTCAATGTCGCCTGTGACCAG-03, (eff%:
PBMC: 103.787%, Placenta: 104.432%),NKp30: Fw primer: 50-CA
TGGTCCATCCAGGATCC-03, Rev primer: 50-GTTCCATTCCT
CACCTCCTTC-03, (eff%:PBMC: 99.125%, Placenta: 100.205%),
NKp30-a: Fw primer: 50-GGTGGTGGAGAAAGAACATC-03,
Rev primer: 50-CTTTCCAGGTCAGACATTTGC-03, (eff%:
PBMC: 102.924%, Placenta: 98.568%), NKp30-b: Fw primer:
50-GGTGGTGGAGAAAGAACATC-03, Rev primer: 50-GAGAG
TAGATTTGGCATATTTGC-03, (eff%:PBMC: 99.486%, Placenta:
98.387%), NKp30-c: Fw primer: 50-GGTGGTGGAGAAAGAA
CATC-03, Rev primer: 50-CATGTGACAGTGGCATTTGC-03,
(eff%:PBMC: 98.145%, Placenta: 101.560%), β-actin: Fw primer:
50-GCATTGTTACCAACTGGGAC-03, Rev primer: 50-GGTCTC
AAACATGATCTGGG-03, (eff%:PBMC: 99.865%, Placenta:
103.251%), IFNγ: Fwprimer: 50-GCCAGGACCCATATGTAAAA
GA-03, Rev Primer: 50-TTCTGTCACTCTCCTCTTTCCAA-03,
(eff%:PBMC: 99.953 5%, Placenta: 100.271%), TNFα: Fw primer:
50-GACAAGCCTGTAGCCCATGT-03, Rev Primer: 50-TTATC
TCTCAGCTCCACGCC-03, (eff%:PBMC: 101.426 5%, Placenta:
100.384%), IL-10: Fw primer: 50-TGCTGGAGGACTTTAAGGG
TTA-03, Rev Primer: 50-ACAGGGAAGAAATCGATGACAG-
03, (eff%:PBMC: 97.45%, Placenta: 100.899%), PLGF: Fw
primer: 50-GATGAGCATGGTGGTTTTCC-03, Rev Primer:
50-AGACACAGGATGGGCTGAAC-03, (eff%:PBMC: 101.981
5%, Placenta: 100.384%), VEGF-A: Fw primer: 50-GCAGAATC
ATCACGAAGTGGT-03, Rev Primer: 50-ATCAGGGTACT
CCTGGAAGATGT-03, (eff%:PBMC: 98.751 5%, Placenta:
99.1%). Target and reference human gene sequences were taken
from the National Center for Biotechnology Information (NCBI,
www.ncbi.nlm.nih.gov).
Statistical Analysis
Graphics and statistical analysis were performed using Graph-
Pad/Prism5 software. Statistical significance was tested using
the two-tailed Mann–Whitney test. Correlation was tested using
Spearman’s rank correlation coefficient. p< 0.05 was considered
statistically significant.







Age (years) 26:1 9:58 29:29 6:89 33:42 6:8
Gravidity 2:3 2:05 2:82 1:81 6:57 2:63
Parity 0:9 1:28 1:58 1:83 2:71 1:6
Spontaneous Ab 0 0 1:17 0:39 4 1:29
Gest. age 8:66 1:42 9:88 1:72 8:85 1:46
aRecurrent (recurrent pregnancy loss).
Age, obstetrical, and infertility histories of women with elective pregnancy termination,
sporadic abortion, and recurrent pregnancy losses, meanS.D.
Results
Thirty-three women consented to participate in the study. These
included 16 patients with sporadic pregnancy loss (“sporadic”
group), 7 patients with recurrent (>2) pregnancy loss (“recurrent”
group), and 10 patients with elective TOP (“control” group).
Demographic and clinical characteristics of the three groups are
summarized in Table 1. No significant differences were noted
between the groups regarding maternal age or gestational age
at performance of the D&C. In the control cases, three placen-
tal tissue samples were excluded from the analyses because of
insufficient RNA yield or purity.
NKp46 Expression, but not NKp30 is Significantly
Enhanced in Pregnancy Loss PBMC
We first evaluated the expression of NKp30 and NKp46 in PBMC,
as these receptors are known to be highly expressed on peripheral
blood NK cells. NKp46 expression was significantly enhanced in
the sporadic group compared to the control group (p= 0.0425,
Figure 1A). NKp46 expression was also elevated in PBMC from
the recurrent group compared with the control group, yet the
results did not reach statistical significance. When we compared
both recurrent and sporadic pregnancy loss cases as a combined
group to the control group, NKp46 expression was significantly
higher (p= 0.049, Figure 1A). NKp30 expression in PBMC sam-
ples showed the same trend in the sporadic and recurrent groups
compared to the control group, yet the differences were not sta-
tistically significant (Figure 1B). We then compared NKp46 and
NKp30 expression in placental tissue samples. In accordance with
PBMC results, NKp46 and NKp30 expressions were enhanced in
the sporadic and recurrent groups as compared to the control
group, as well as for the combined group of sporadic and RPL;
however, only for the combined sporadic and recurrent groups
were NKp46 elevation statistically significant relative to the con-
trol group. (Figures 1C,D). Note that 10/33 individual samples are
marked with colored-filled symbols instead of black-filled sym-
bols for following their analysis throughout all relevant figures.
These 10 samples were chosen based on their high expression of
one NKp30 isoform (Figure 2).
NKp30-a and NKp30-b Expression in the
Placental Tissue is Significantly Elevated in
Sporadic and Recurrent Pregnancy Loss
NKp30 mRNA can be transcribed as three major splice vari-
ants: NKp30-a, NKp30-b, and NKp30-c (19). Although NKp30
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FIGURE 1 | NKp46 expression but not NKp30 is enhanced in
pregnancy loss PBMC. NKp46 and NKp30 expression analysis in PBMC
and placental tissue of patients undergoing elective, sporadic, or recurrent
pregnancy loss. The dot plot represents data of each patient (dotted) in each
group. Bars= group meanSD (A) NKp46 mRNA (PBMC). (B) NKp30
mRNA (PBMC). (C) NKp46 mRNA (Placenta). (D) NKp30 mRNA (Placenta).
Statistics: Mann–Whitney test, two-tailed (*p<0.05). Ten out of the 33
individual samples are marked with colored-filled symbols (, ,N,H)
instead of black-filled symbols for following their analysis throughout all
relevant figures.
FIGURE 2 | NKp30-a and NKp30-b expression in the placental tissue is
significantly elevated in sporadic and recurrent pregnancy loss. mRNA
expression analysis of NKp30 isoforms in PBMC and placenta tissue samples of
patients undergoing elective, sporadic, or recurrent pregnancy loss. The dot plot
represents data of each patient (dotted) in each group. Bars= group
meanSD (A.1) NKp30-a mRNA (PBMC), (A.2) NKp30-a mRNA (Placenta),
(B.1) NKp30-b mRNA (PBMC), (B.2) NKp30-b mRNA (Placenta), (C.1)
NKp30-c mRNA (PBMC), (C.2) NKp30-c mRNA (Placenta), in color
(demonstrated in PBMC) are individuals with a high NKp30-c profile, relative to
other low NKp30-c profile samples. The NKp30-c profile in placenta tissue of
the same individuals is also shown. Statistics: Mann–Whitney test, two-tailed
(*p<0.05). Ten out of the 33 individual samples are marked with colored-filled
symbols (, ,N,H) instead of black-filled symbols for following their
analysis throughout all relevant figures.
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FIGURE 3 | Continued
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FIGURE 3 | Continued
NKp30 isoforms ratio is different between PBMC and placenta tissue in
sporadic and recurrent pregnancy loss. Ratio analysis of NKp30 isoforms
per sample (median bars=median values, whiskers: Min to Max). Comparison
between groups: elective, sporadic, and recurrent pregnancy loss in (1) PBMC
and (2) placenta. Comparison between samples: PBMC and placenta in (3)
elective, (4) sporadic, and (5) recurrent pregnancy loss. (A.1–5)
NKp30-a/NKp30-b ratio. (B.1–5) NKp30-a/NKp30-c ratio.
(C.1–5) NKp30-b/NKp30-c ratio. Statistics: Mann–Whitney test, two-tailed
(*p<0.05).
expression did not statistically differ among pregnancy abortion
groups in PBMC and placental tissue samples, we focused on
the expression of NKp30-a, NKp30-b, and NKp30-c isoforms, as
different NKp30 isoform profiles can lead to diverse functions of
NK cells.
In accordance with total NKp30 expression, the group expres-
sion of NKp30-a and NKp30-b in PBMC was higher in the spo-
radic and recurrent groups compared with the control group,
but this difference was not statistically significant (Figures 2A.1,
B.1). The NKp30-c mean group expression in the PBMC samples
was significantly elevated, which can be explained by NKp30-
c profile individuals (Figure 2C.1, colored dots). In contrast
to the PBMC samples, NKp30 isoform expression in the pla-
cental tissue showed a different trend. NKp30-a and NKp30-b
expression was significantly elevated in the sporadic group. In
the recurrent group, NKp30-a elevation was close to statistically
significant, while NKp30-b elevation was statistically significant
(Figures 2A.2, B.2). However, NKp30-c expression did not show
any statistically significant differences among pregnancy abortion
groups (Figure 2C.2, colored dots).
NKp30 Isoform Ratio is Different Between PBMC
and Placenta Tissue in Sporadic and Recurrent
Pregnancy Loss
Zitvogel et al. have shown that the ratio between NKp30 isoforms
can predict the clinical outcome of patients with GISTs (19).
We thus studied whether a NKp30 isoform ratio could also be
employed as a marker for first trimester pregnancy loss. The
NKp30 isoform ratio in PBMC samples did not significantly dif-
fer between the selected groups (Figures 3A.1, B.1, C.1). The
only significant change was observed in the NKp30-a/NKp30-b
ratio, which was elevated in the placenta samples obtained from
sporadic abortions, indicating an increase in NKp30-a relative to
NKp30-b (Figures 3A.2, B.2, C.2). As we previously observed,
NKp30-c profile differed in a tissue-specific manner. We then
compared NKp30 isoform ratios in PBMC to placenta tissue in
each pregnancy abortion group. The NKp30 isoform ratio in
the elective control group did not significantly differ between
PBMC and corresponding placental tissue (Figures 3A.3, B.3,
C.3). In the sporadic group, NKp30-a/NKp30-b and NKp30-
a/NKp30-c, but not NKp30-b/NKp30-c, ratios were significantly
elevated in the placenta tissue compared to corresponding PBMC
samples, indicating an increase in NKp30-a relative to NKp30-
b and NKp30-c (Figures 3A.4, B.4, C.4). The same trend was
seen in the recurrent group, as NKp30-a/NKp30-c was sig-
nificantly elevated in the placental tissue compared to corre-
sponding PBMC (Figures 3A.5, B.5, C.5). This data points to
a tissue-specific up-regulation of NKp30-a relative to NKp30-
b and NKp30-c in the placenta during first trimester preg-
nancy loss.
Placental Expression of NKp30-a and NKp30-b is
Negatively Correlated with Placental PLGF
Expression in Sporadic and Recurrent Pregnancy
Loss
El Costa et al. and Hanna et al. previously showed that NKp30
engagement promote cytokine synthesis and secretion, among
them IFNγ, TNFα, IL-10, PLGF, and VEGF-A, by dNK in the
placental tissue (15, 16). Expression of selected cytokines did
not show any significant difference among the groups in PBMC
samples with the exception of TNFα, which was decreased in
the sporadic group relative to the control group (Figures 4A.1,
B.1, C.1, D.1, E.1). When comparing the pregnancy abortions
groups in placental tissue, IFNγ, TNFα, IL-10, but not VEGF-A
were significantly elevated in the sporadic but not in the recur-
rent group. PLGF expression was decreased in both the sporadic
and recurrent abortion groups compared to the control group
(Figures 4A.2, B.2, C.2, D.2, E.2). We then examined the corre-
lation between NKp46 and NKp30, as well as NKp30 isoforms to
early pregnancy-related cytokines (Figures 4F,G). Control group
PBMC samples showed a positive correlation betweenNKp46 and
IFNγ and a negative correlation between NKp46 and NKp30 to
IL-10. This trend was lost in the sporadic and recurrent PBMC
samples. Excluding that, a specific correlation pattern could not
be seen in PBMC samples obtained from control, sporadic, and
recurrent first trimester pregnancy loss cases.
In contrast to PBMC, placenta tissue samples showed a specific
correlation pattern. In the elective, control group, positive corre-
lations were seen between NKp46 and NKp30 to IFNγ, TNFα,
IL-10, and VEGF-A. NKp30-a and NKp30-b kept the same cor-
relation pattern as NKp46 and NKp30, with the exception of
the correlation to IFNγ that was lost. In the sporadic placenta
tissue samples, this correlation pattern was lost. However, neg-
ative correlations between PLGF and NKp46, NKp30, NKp30-a,
and NKp30-b were observed. This negative correlation of NKp30
activating isoforms to PLGF was repeated in the RPL placenta
samples.
Discussion
First trimester pregnancy losses are a common complication
of early pregnancy. Throughout human pregnancy, the geneti-
cally “foreign” semi-allogeneic fetus and placenta evade mater-
nal immune responses (20). Successful pregnancy requires sup-
pression of the mother’s immune system, enabling an immune-
tolerant state. NK cells are thought to play an important role, serv-
ing as the predominant cell type in this process (21). NKp46 and
NKp30 are primary activating receptors, expressed constitutively
byNK cells, and their engagement can stimulateNK function (14).
In the present study, we have examined in parallel the expression
of NKp46 and NKp30 in both peripheral blood and placenta
tissue (decidua) samples, comparing women with sporadic and
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FIGURE 4 | Continued
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FIGURE 4 | Continued
Placental expression of NKp30-a and NKp30-b is negatively correlated
with placental PLGF expression in sporadic and recurrent pregnancy
loss. IFNγ, TNFα, IL-10, PLGF, and VEGF-A mRNA expression analysis in (1)
PBMC and (2) placenta tissue of patients undergoing elective, sporadic, or
recurrent pregnancy loss. The dot plot represents data of each patient (dotted)
in each group, Bars= group meanSD (A.1,2) IFNγ, (B.1,2) TNFα, (C.1,2)
IL-10, (D.1,2) PLGF, and (E.1,2) VEGF-A. (F) Correlations in PBMC samples.
(G) Correlations in placental tissue samples. Spearman’s rank correlation,
(*p<0.05). Ten out of the 33 individual samples are marked with colored-filled
symbols (, ,N,H) instead of black-filled symbols for following their
analysis throughout all relevant figures.
recurrent spontaneous abortions to elective first trimester preg-
nancy terminations. Zhang et al. reported a significantly higher
expression of NKp46, and a higher but not significant expression
of NKp30, on CD56dimCD16+ dNK cells in women with sponta-
neous abortion compared with elective abortions (22). In accor-
dance with the study by Zhang et al. in the present study, placenta
NKp46 expression levelswere significantly enhanced in pregnancy
loss groups (combined) vs. the control elective group (Figure 1C),
while placenta NKp30 expression levels were enhanced but not
significantly (Figure 1D).
The report by Zhang et al. has discussed that the differences
in NCR-expression correlate with a higher activity of dNK cells
derived from spontaneous abortions. To better assess the NKp30
role in dNK activity in pregnancy loss, we have expanded NCR-
expression studies to include NKp30 isoform expression, adding
pioneer information in regard to this expression in our clinical
set-up. NKp30 isoforms were reported to have opposite roles in
NKp30 function, with NKp30-c bearing an inhibitory function
compared to the activating functions of NKp30-a and NKp30-
b (19). NKp30-a and NKp30-b were enhanced in the placenta
samples of both sporadic and RPL compared to the control group
(Figures 2A.2, B.2). This was unique to NKp30-a and NKp30-b
in the placenta and was not observed in PBMC. Zitvogel et al.
have previously published that an NKp30 isoform profile can
be divided into NKp30-c or NKp30-a/b profile individuals (19).
The expression of NKp30-c in the placenta did not differ signifi-
cantly among the three groups. Nevertheless, in PBMC, NKp30-c
mean group expressionwas significantly enhanced in the sporadic
pregnancy loss vs. the control group (Figures 2C.1, C.2). This
difference could be attributed to few patients bearing NKp30-c
profile (high NKp30-c and low NKp30-a/b expression in PBMC).
We marked 10 individuals expressing high levels of at least one
isoform by specific coloring of their symbols (Figures 1, 2, and 4).
As expected (18), patients bearing NKp30-c profile expressed low
levels of the NKp30-a/b isoforms in PBMC; yet, not all placenta
tissue samples corresponding to PBMC samples with NKp30-
c profile showed the same profile (Figure 2, colored symbols).
This phenomenon may point to a tissue-specific NKp30 isoforms
profiles and will need to be addressed further.
We also investigated the NKp30 isoforms ratio profile, calcu-
lated per each patient, as a prognostic marker for the risk of abor-
tion.We took this approach in accordancewith the study by Zitvo-
gel and colleagues regarding the prognosis of HIV patients (18).
We concentrated on blood PBMC as surrogate tissue, but neither
of the three mean NKp30 isoforms ratios (a/b, a/c, and b/c) was
significantly different among the groups’ PBMC (Figures 3A.1,
B.1, C.1). Analysis of the NKp30 isoforms ratios in placenta
samples shows that the NKp30-a/NKp30-b ratio increased in the
sporadic group, indicating an up-regulation in the expression of
NKp30-a. The same trend was seen when comparing isoforms
ratios between PBMC and placenta samples in the sporadic group
and partially in the recurrent group, but not in the control group
(Figures 3A.4, B.4, B.5). Because NKp30 isoforms ratios could
not be subject to changes in dNK numbers, this up-regulation of
NKp30-a, an activation isoforms ofNKp30,may indicate extensive
activation or/and function of dNK, as was reported by Zhang
et al. (22).
NKp30 on dNK was reported to mediate pregnancy-related
cytokine synthesis and secretion (15, 16). Fukui et al. previ-
ously reported, in PBMC, that the correlation between NCRs and
selected cytokines was lost in RPL (23). Similarly in our study,
in PBMC, correlation to selected cytokines was lost in sporadic
and recurrent groups (Figure 4F). In the placenta tissue, a signif-
icant positive correlation was seen in the elective control group
to IFNγ, TNFα, IL-10, and VEGF-A. By contrast, the sporadic
and recurrent groups did not show the same correlation pattern;
however, a significant negative correlation was seen to PLGF,
an angiogenesis factor that was recently suggested as a marker
for early pregnancy loss (Figure 4G) (24–28). These data may
point out a possible positive role of NKp30-a and NKp30-b in
the promotion of early pregnancy placenta development that is
disrupted in early pregnancy loss.
Furthermore, we showed that NKp30-a and NKp30-b but not
NKp30-c were up-regulated in sporadic and recurrent placenta
samples. Hanna et al. showed that adherent decidual cells express
unknown NKp30 ligands (NKp30L), which in turn may mediate
cytokine secretion throughNKp30, as was shown by El Costa et al.
(15, 16). It may be that this up-regulation of activation isoforms of
NKp30 is a compensatory process for a lack of NKp30–NKp30L
recognition, which in turn damages trophoblast invasion, marked
by a low expression of PLGF; yet, this hypothesis still needs to be
examined.
Overall, our observations correlate with previous publications
regarding the enhancement of placenta NKp46 expression during
spontaneous pregnancy loss. In addition, our results shed new
light on the contribution of NKp30 by demonstrating (i) changes
in NKp30 isoform status between the peripheral blood and pla-
centa in pregnancy loss, and (ii) changes between elective and
spontaneous pregnancy loss in regard to NKp30 isoform status.
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